Payment overview · 2025
General Payments
2 reported records · 2 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Internal Medicine · HIALEAH, FL · NPI 1043269863
Verified facts
CMS Open Payments records show Juan C Abreu, MD received $132.60 in general payments during 2025 across 2 reported records.
Medtronic, Inc. accounted for 88.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
2 reported records · 2 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$117.16 | 88.4% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $15.44 | 11.6% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $132.60 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AVALUS Normalized: avalus |
Device | Medtronic, Inc. | $117.16 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $15.44 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Temazepam | Temazepam | 221 | 29 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 193 | 58 |
| Levothyroxine Sodium | Levothyroxine Sodium | 179 | 46 |
| Atorvastatin Calcium | Atorvastatin Calcium | 177 | 63 |
| Metformin Hcl | Metformin Hcl | 174 | 48 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 164 | 39 |
| Omeprazole | Omeprazole | 160 | 48 |
| Pantoprazole Sodium | Pantoprazole Sodium | 151 | 51 |
| Gabapentin | Gabapentin | 148 | 44 |
| Amlodipine Besylate | Amlodipine Besylate | 144 | 52 |
| Alprazolam | Alprazolam | 137 | 26 |
| Lisinopril | Lisinopril | 120 | 41 |
| Metoprolol Succinate | Metoprolol Succinate | 118 | 35 |
| Losartan Potassium | Losartan Potassium | 112 | 46 |
| Tamsulosin Hcl | Tamsulosin Hcl | 101 | 31 |
| Diclofenac Sodium | Diclofenac Sodium | 99 | 33 |
| Clopidogrel | Clopidogrel Bisulfate | 91 | 31 |
| Baclofen | Baclofen | 86 | 36 |
| Metoprolol Tartrate | Metoprolol Tartrate | 76 | 25 |
| Azithromycin | Azithromycin | 71 | 58 |
| Eliquis | Apixaban | 69 | 25 |
| Famotidine | Famotidine | 67 | 28 |
| Januvia | Sitagliptin Phosphate | 67 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 64 | suppressed |
| Memantine Hcl | Memantine Hcl | 62 | 16 |
| Hydrochlorothiazide | Hydrochlorothiazide | 61 | 26 |
| Furosemide | Furosemide | 58 | 25 |
| Simvastatin | Simvastatin | 58 | 18 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 56 | 24 |
| Prednisone | Prednisone | 56 | 25 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 55 | 36 |
| Donepezil Hcl | Donepezil Hcl | 54 | 17 |
| Tramadol Hcl | Tramadol Hcl | 53 | 19 |
| Quetiapine Fumarate | Quetiapine Fumarate | 50 | 13 |
| Sertraline Hcl | Sertraline Hcl | 49 | 21 |
| Buspirone Hcl | Buspirone Hcl | 48 | 12 |
| Montelukast Sodium | Montelukast Sodium | 47 | 17 |
| Lorazepam | Lorazepam | 46 | suppressed |
| Mupirocin | Mupirocin | 46 | 24 |
| Mirtazapine | Mirtazapine | 45 | 17 |
| Alendronate Sodium | Alendronate Sodium | 42 | 18 |
| Vascepa | Icosapent Ethyl | 41 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 40 | 12 |
| Carvedilol | Carvedilol | 39 | 11 |
| Meclizine Hcl | Meclizine Hcl | 39 | 18 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 37 | 17 |
| Lactulose | Lactulose | 37 | 13 |
| Ozempic | Semaglutide | 37 | 11 |
| Clonazepam | Clonazepam | 35 | suppressed |
| Levofloxacin | Levofloxacin | 35 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 34 | 14 |
| Meloxicam | Meloxicam | 33 | suppressed |
| Atenolol | Atenolol | 32 | suppressed |
| Pregabalin | Pregabalin | 32 | suppressed |
| Glipizide | Glipizide | 31 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 30 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 30 | suppressed |
| Entresto | Sacubitril/Valsartan | 29 | suppressed |
| Ibuprofen | Ibuprofen | 29 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 28 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 27 | suppressed |
| Linzess | Linaclotide | 27 | suppressed |
| Nifedipine Er | Nifedipine | 27 | 11 |
| Potassium Chloride | Potassium Chloride | 27 | suppressed |
| Glipizide Er | Glipizide | 26 | suppressed |
| Finasteride | Finasteride | 25 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 25 | suppressed |
| Metronidazole | Metronidazole | 25 | 18 |
| Folic Acid | Folic Acid | 24 | suppressed |
| Methylprednisolone | Methylprednisolone | 24 | 21 |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 23 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Hydrocortisone | Hydrocortisone | 22 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 21 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 21 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 21 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 20 | suppressed |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 20 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 20 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 20 | suppressed |
| Synthroid | Levothyroxine Sodium | 20 | suppressed |
| Benzonatate | Benzonatate | 19 | 17 |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 19 | suppressed |
| Latanoprost | Latanoprost | 18 | suppressed |
| Naproxen | Naproxen | 18 | suppressed |
| Allopurinol | Allopurinol | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | 13 |
| Glimepiride | Glimepiride | 15 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 15 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 15 | suppressed |
| Telmisartan | Telmisartan | 15 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 14 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 14 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 13 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Methotrexate | Methotrexate Sodium | 13 | suppressed |
| Olanzapine | Olanzapine | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Tadalafil | Tadalafil | 13 | suppressed |
| Xarelto | Rivaroxaban | 13 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Pentoxifylline | Pentoxifylline | 12 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 11 | suppressed |
| Ciclopirox | Ciclopirox | 11 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 11 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $132.60 · 2 records | Medtronic, Inc. | AVALUS, The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error